Ribbon Acquisition shareholders approve DRC Medicine deal; heavy redemptions leave $1.4M trust

Ribbon Acquisition Corp.

All 8 proposals passed, including Business Combination with DRC Medicine Ltd. (2,835,534 for, 371,112 against).
Domestication to Delaware approved; also Charter NTA amendment, Nasdaq issuance, Incentive Plan, director elections.
Redemptions: 3,460,471 shares tendered; after 30,633 reversals, 3,429,838 remain subject to redemption (~$36,321,984.42).
Trust account balance after redemptions ~$1,411,594.05; per-share redemption price ~$10.59.
Seven Pubco directors elected, including Narumi Okazaki, Akira Okada, Shigeo Kamitsuji, etc.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.